Home >> Signaling Pathways >> Immunology/Inflammation

Immunology/Inflammation(免疫及炎症)

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Products for  Immunology/Inflammation

  1. Cat.No. 产品名称 Information
  2. GC60408 (R)-Verapamil hydrochloride

    R-维拉帕米,(R)-(+)-Verapamil hydrochloride

    (R)-Verapamilhydrochloride((R)-(+)-Verapamilhydrochloride)是一种P-糖蛋白(P-Glycoprotein)抑制剂。(R)-Verapamilhydrochloride抑制MRP1介导的转运,导致MRP1过表达细胞对抗癌药产生化学敏感性。
  3. GC60407 (R)-Verapamil D7 hydrochloride

    (R)-(+)-Verapamil D7 hydrochloride

    (R)-VerapamilD7hydrochloride((R)-(+)-VerapamilD7hydrochloride)是(R)-Verapamilhydrochloride的一种氘代化合物。(R)-Verapamilhydrochloride((R)-(+)-Verapamilhydrochloride)是一种P-糖蛋白抑制剂。(R)-Verapamilhydrochloride抑制MRP1介导的转运,导致MRP1过表达细胞对抗癌药产生化学敏感性。
  4. GC60398 (6R)-FR054

    (3AR,7AR)-5-(乙酰氧基甲基)-2-甲基-5,6,7,7A-四氢-3AH-吡喃并[3,2-D]噁唑-6,7-叉基二醋酸盐

    (6R)-FR054是FR054的一个活性异构体。FR054是HBP酶PGM3的抑制剂,具有显著的抗乳腺癌活性。FR054可诱导内质网应激和ROS依赖的细胞凋亡。
  5. GC60397 (5Z,2E)-CU-3 A DGK-α inhibitor
  6. GC19070 LMT-28 LMT-28 是一种具有口服活性的合成 IL-6 抑制剂,通过直接结合 gp130 发挥作用。
  7. GC46241 7-keto Cholesterol-d7

    7-酮基胆固醇-D7,7-oxo Cholesterol-d7

    An internal standard for the quantification of 7-keto cholesterol
  8. GC18773 (Rac)-Benpyrine An inhibitor of the TNF-α-TNFR1 protein-protein interaction
  9. GC60377 Urolithin C

    尿石素C

    UrolithinC,是鞣花酸的多酚类肠道微生物代谢产物,是胰岛素分泌(insulinsecretion)的葡萄糖依赖性激活剂。UrolithinC是一种L型Ca2+通道开放剂,可增强Ca2+的流入。UrolithinC通过线粒体介导的途径诱导细胞凋亡(apoptosis),并刺激活性氧(ROS)的形成。
  10. GC60376 UC2288 UC2288 is a novel, cell-permeable, and orally active p21 attenuator, decreases p21 mRNA expression independently of p53, and attenuates p21 protein levels with minimal effect on p21 protein stability.
  11. GC60364 Thienopyridone Thienopyridone 是一种有效的选择性的肝再生磷酸酶 (PRL) 磷酸酶抑制剂,对于 PRL-1,PRL-2 和 PRL-3,IC50 值分别为 173 nM,277 nM 和 128 nM。Thienopyridone 对其他磷酸酶的影响很小。Thienopyridone 可诱导 p130Cas 裂解和细胞凋亡 (apoptosis),并具有抗癌作用。
  12. GC60354 Tat-NR2Baa Tat-NR2BAA 是 Tat-NR2B9c 的对照肽 (control peptide),没有活性。Tat-NR2BAA 的序列与 Tat-NR2B9c 相似,但在 COOH 末端 tSXV 基序中有一个双点突变,这使得它无法结合 PSD-95。Tat-NR2B9c 是一种可通透细胞膜的多肽,破坏 PSD-95/NMDAR 的结合。
  13. GC60352 Taraxerol

    蒲公英萜醇

    Taraxerol 具有抗炎和抗癌作用。
  14. GC60348 Supinoxin

    RX-5902

    Supinoxin (RX-5902) 是磷酸化 p68 RNA 解旋酶 (P-p68) 的强效口服活性抑制剂,并且是一个一流的抗肿瘤试剂 (anti-cancer agent)。Supinoxin 与 Y593 磷酸化的 p68 相互作用并减弱 β-catenin 的核穿梭性。 Supinoxin 诱导细胞凋亡 (apoptosis) 并抑制 TNBC 癌细胞系的生长,IC50 的范围为 10 nM 至 20 nM。
  15. GC60344 Sparstolonin B An isocoumarin with diverse biological activities
  16. GC60339 SKI V

    2-(3,4-二羟基亚苄基)苯并呋喃-3(2H)-酮

    SKI V is a noncompetitive and potent inhibitor of non-lipid sphingosine kinase with IC50 of 2 μM for GST-hSK. SKI-V also inhibits PI3K with IC50 of 6 μM for hPI3k. SKI-V decreases formation of the mitogenic second messenger sphingosine-1-phosphate (S1P) and induces apoptosis with antitumor activity.
  17. GC60336 SEC SEC通过AMPK/mTORC1/STAT3信号通路诱导ANXA7GTPase的激活。SEC选择性的促进癌细胞的凋亡,诱导ITGB4核转位,表达高水平ITGB4。
  18. GC60331 Rubiadin-1-methyl ether

    甲基异茜草素-1-甲醚

    An anthraquinone with diverse biological activities
  19. GC60328 Robinin

    刺槐素

    Robinin 是一种存在于 Vigna unguiculata 叶中的类黄酮。Robinin 抑制 TLR2 和TLR4 的表达上调。Robinin 通过 TLR4/NF-κB 通路改善氧化的低密度脂蛋白 (Ox-LDL) 引起的炎症损伤。
  20. GC60327 RO2959 hydrochloride RO2959hydrochloride是一种有效的选择性CRAC通道抑制剂,IC50为402nM。RO2959hydrochloride是由Orai1/Stim1通道介导的钙存储进入(SOCE)的有效阻滞剂,IC50为25nM。RO2959hydrochloride还是人IL-2产生的有效抑制剂,有效阻断T细胞受体触发的基因表达和T细胞功能途径。
  21. GC60325 Rilmenidine

    利美尼啶

    An antihypertensive agent
  22. GC60317 RA-9

    (3E,5E)-3,5-双(4-硝基亚苄基)哌啶-4-酮

    RA-9 is a cell-permeable, potent and selective inhibitor of proteasome-associated deubiquitinating enzymes (DUBs) with favorable toxicity profile and anticancer activity. RA-9 selectively induces apoptosis in ovarian cancer cell lines.
  23. GC60297 Polyinosinic-polycytidylic acid sodium

    双链聚肌胞; Poly(I:C)

    Polyinosinic-polycytidylic acid sodium (Poly I:C)是一种合成的dsRNA,可以模拟病毒感染,并通过触发特定的模式识别受体(PRRs),如toll样受体3(TLR3)和维甲酸诱导基因I(RIG-I)样受体,包括RIG-I和黑色素瘤分化相关基因5,引发宿主免疫反应。
  24. GC60288 Picrocrocin

    苦番紅花素

    Picrocrocin, the chemical most responsible for the bitter taste of saffron, is isolated from saffron and inhibits proliferation of cancer cells.
  25. GC60283 Pentagamavunon-1

    PGV-1

    Pentagamavunon-1 (PGV-1) 是Curcumin 的类似物,具有口服活性,通过多个机制诱导凋亡信号,如抑制COX-2 和 VEGF。Pentagamavunon-1 (PGV-1) 可抑制 NF-κB 的激活。
  26. GC60268 Neoxanthin

    新黄质

    Neoxanthin是深绿色多叶蔬菜中的一种主要的叶黄素类胡萝卜素,是一种植物激素脱落酸的前体。Neoxanthin是一种有效的抗氧化剂和集光颜料,诱导细胞凋亡(apoptosis)并具有抗癌作用。

  27. GC60267 Neocryptotanshinone

    新隐丹参酮

    Neocryptotanshinone是可从SalviaMiltiorrhiza分离得到的一种丹参二萜,通过抑制NF-κB和iNOS信号来抑制LPS诱导的炎症。
  28. GC60264 Naphthazarin

    萘茜,DHNQ; 5,8-Dihydroxy-1,4-naphthoquinone

    Naphthazarin(DHNQ)是天然存在的化合物,通过多种细胞机制有效,包括氧化应激,线粒体凋亡诱导因子(AIF)活化,微管解聚,干扰溶酶体功能和p53依赖性p21活化。Naphthazarin触发细胞凋亡(apoptosis)并具有抗肿瘤作用。
  29. GC60259 MYCMI-6

    NSC354961

    MYCMI-6 (NSC354961) 是一种有效的选择性内源性 MYC:MAX 蛋白相互作用抑制剂。 MYCMI-6 阻断 MYC 驱动的转录。MYCMI-6 选择性结合 MYC bHLHZip 域,Kd 值为 1.6 μM。MYCMI-6 以 MYC 依赖性的方式抑制肿瘤细胞的生长 (IC50<0.5 μM)。MYCMI-6 对正常人细胞无细胞毒性。MYCMI-6 诱导细胞凋亡 (apoptosis)。
  30. GC60258 MT 63-78 MT 63-78 是一种有效的直接 AMPK 激活剂,EC50 为 25 μM。M 63-78 还诱导细胞有丝分裂阻滞和细胞凋亡 (apoptosis)。MT 63-78 通过抑制脂肪生成和 mTORC1 途径来阻止前列腺癌的生长。MT 63-78 具有抗肿瘤作用。
  31. GC60241 Melatonin D5

    褪黑素 D5; N-Acetyl-5-methoxytryptamine-d4

    An internal standard for the quantification of melatonin
  32. GC60221 Lactoferrin (17-41) (acetate)

    Lactoferricin B acetate; Lfcin B acetate

    Lactoferrin 17-41 (Lactoferricin B) acetate 对应于牛乳铁蛋白的残基 17-41,对革兰氏阳性和革兰氏阴性细菌、病毒、原生动物和真菌等多种微生物具有抗菌活性。Lactoferrin 17-41 acetate 具有抗肿瘤活性。
  33. GC60183 GSK2245035 A TLR7 agonist
  34. GC60182 GSK046

    iBET-BD2

    A BD2 bromodomain inhibitor
  35. GC60180 Gossypin

    棉纤维素

    A flavonoid glycoside with diverse biological activities
  36. GC60173 Ginsenoside F5

    人参皂苷F5

    GinsenosideF5,可从Panaxginseng中提物,通过凋亡(apoptosis)途径显着抑制HL-60细胞生长。
  37. GC60159 Ezetimibe ketone

    (3R,4S)-1-(4-氟苯基)-3-[3-(4-氟苯基)-3-氧代丙基]-4-(4-羟基苯基)氮杂环丁烷-2-酮,EZM-K

    Ezetimibe ketone (EZM-K) 是 Ezetimibe 的 I 期代谢产物。Ezetimibe 是一种 NPC1L1 抑制剂,是有效的 Nrf2 激活剂,Ezetimibe 还是有效的胆固醇吸收抑制剂。
  38. GC60157 Euphorbia Factor L2

    大戟因子L2

    Euphorbia factor L2 是从大戟种子中分离得到的一种赤藓烷二萜 (Euphorbia lathyris L.),传统上用于治疗癌症。Euphorbia factor L2 显示强烈的细胞毒性并通过线粒体途径诱导细胞凋亡。
  39. GC60153 Eriocalyxin B

    毛萼乙素

    EriocalyxinB是从中草药枇杷素中分离得到的一种二萜类化合物。EriocalyxinB具有抗癌、抗炎作用。EriocalyxinB诱导细胞凋亡(apoptosis)。
  40. GC60152 Epibetulinic acid

    表白桦脂酸

    Epibetulinic acid 从 Maytenus cuzcoina 的根皮和 Maytenus chiapensis 的叶子中分离出的。Epibetulinic acid 作用于用细菌内毒素刺激的小鼠巨噬细胞 (RAW 264.7),抑制 NO 和前列腺素 E2 (PGE2) 产生,IC50 分别为 0.7 和 0.6 μM。具有抗炎活性。
  41. GC60149 EG01377 dihydrochloride EG01377dihydrochloride是有效的、可生物利用的和选择性的neuropilin-1(NRP1)抑制剂,Kd值为1.32μM,对NRP1-a1和NRP1-b1的IC50值均为609nM。EG01377dihydrochloride具有抗血管生成,抗迁移及抗肿瘤等活性。
  42. GC60129 Deoxyelephantopin

    去氧地胆草素

    Deoxyelephantopin是一种来自Elephantopusscaber的,具有生物活性的天然倍半萜烯内酯。可广泛用于癌症方面的研究。Deoxyelephantopin抑制NF-κB,MAPK,PI3K/Akt和β-catenin信号传导。
  43. GC60111 Clitocine

    克力托辛

    Clitocine是一种腺苷核苷类似物,是一种有效的通透剂(readthrough)。Clitocine可诱导携带p53无义突变等位基因的细胞产生p53蛋白。Clitocine可通过靶向Mcl-1诱导多药耐药肿瘤细胞凋亡。具有抗癌活性。
  44. GC60076 Bigelovin

    锦菊素

    Bigelovin是可从海百合中分离得到的一种倍半萜内酯,是选择性的视黄素X受体α(retinoidXreceptorα)的激动剂。Bigelovin可通过诱导凋亡和自噬来发挥抗肿瘤活性。Bigelovin通过抑制ROS的生成来调节mTOR信号通路。
  45. GC60040 ADH-503

    (Z)-Leukadherin-1 choline

    ADH-503 (GB1275, (Z)-Leukadherin-1 choline) is the salt form of leukadherin-1 and acts as a potent allosteric agonist of CD11b.
  46. GC60008 (S)-Verapamil hydrochloride

    S-维拉帕米,(S)-(-)-Verapamil hydrochloride

    (S)-Verapamil hydrochloride (S(-)-Verapamil hydrochloride) 通过 MRP1 抑制白三烯 C4 (LTC4) 和钙黄绿素的转运。(S)-Verapamil hydrochloride 导致潜在耐药性肿瘤细胞死亡。
  47. GC18572 Concanavalin A

    刀豆蛋白

    Concanavalin A属于concanamycin,这是一种从异色链霉菌中分离出来的大环内酯类抗生素,是液泡质子- atp酶(v-[H[+]] atp酶)的高活性和选择性抑制剂。

  48. GC18533 ZLDI-8 ZLDI-8 是一种 Notch 激活/切割酶 ADAM-17 抑制剂,可抑制 Notch 蛋白的切割。 ZLDI-8 降低促存活/抗凋亡和上皮间质转化 (EMT) 相关蛋白的表达。 ZLDI-8 还是一种竞争性且不可逆的酪氨酸磷酸酶 (Lyp) 抑制剂,IC50 为 31.6 μM,Ki 为 26.22 μM。 ZLDI-8 抑制 MHCC97-H 细胞的生长,IC50 为 5.32 μM。
  49. GC39827 HM03

    4-((6-氯-2-甲氧基吖啶-9-基)氨基)-2-((4-甲基哌嗪-1-基)甲基)苯酚

    HM03 是一种有效的选择性的热休克 70 kDa 蛋白 5, HSPA5 (也称为 Bip,Grp78) 抑制剂,具有抗肿瘤活性。
  50. GC39820 Lometrexol hydrate

    洛美曲索水合物,DDATHF hydrate

    A GART inhibitor
  51. GC39815 Semapimod tetrahydrochloride

    CNI-1493; CPSI-2364 tetrahydrochloride

    Semapimod tetrahydrochloride (CNI-1493) 是促炎细胞因子产生 (proinflammatory cytokine) 的抑制剂,可抑制TNF-α、IL-1β 和 IL-6。Semapimod tetrahydrochloride 抑制巨噬细胞 p38 MAPK 和一氧化氮生成。Semapimod tetrahydrochloride 抑制 TLR4 信号 (IC50≈0.3 μM)。Semapimod tetrahydrochloride 在多种炎症和自身免疫性疾病中具有潜在的作用。

Items 2201 to 2250 of 4243 total

per page

Set Descending Direction